FDAnews Device Daily Bulletin
Sept. 24, 2012 | Vol. 9 No. 187
Eli Lilly has misbranded its radioactive PET drug Amyvid, approved for reviewing displays of brain scans using a black-and-white scale, by featuring a multi-colored brain image on a web page advertisement and other promotional materials for the product, according to an FDA untitled letter.
The European Commission is seeking the go-ahead from member states on a free trade agreement that would promote access to European medical devices in Japan.
The National Republican Congressional Committee (NRCC) is renewing its attack on the healthcare law’s 2.3 percent tax on medical devices.
A new pediatric medical device being developed by Georgia Tech and Emory University could make life easier for every parent who has rushed to the doctor with a child screaming from an ear infection.
St. Jude Medical announced it has received European CE Mark approval of its Eon family of neurostimulators for patients with intractable chronic migraine.
Titan Spine announced it has been awarded a patent by the USPTO protecting the company against competitive interbody devices with a roughened surface topography, anti-expulsion edges and access to a hollow center.
Smiths Medical announced that its Portex CorrectInject Safety System for administering neuraxial (spinal and epidural) medication received 510(k) clearance from the FDA.
Dune Medical Devices announced results of a study published in the journal Nature.com demonstrating the utility of the MarginProbe technology in prostate cancer surgery.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.